FDA mulls regulatory action on Sprout's 'female Viagra' after adverse events spike

Before there was Biogen’s Aduhelm, there was Sprout Pharmaceuticals’ “female Viagra” pill Addyi. Both FDA-approved drugs stirred up significant controversy because their approvals were based on limited efficacy data and lingering safety concerns.